Sources of the figures for Timor-Leste
| Source | Type | Rows | Indicators | Years | Read from | Retrieved |
|---|---|---|---|---|---|---|
| UNAIDS AIDSinfo | Modelled estimate | 553 | 23 | 2000–2024 | aidsinfo.unaids.org | 2026-10-20 |
| UNICEF HIV/AIDS dataset | Modelled estimate | 432 | 3 | 2010–2025 | sdmx.data.unicef.org | 2026-10-20 |
| WHO Global Health Observatory | Modelled estimate | 192 | 11 | 2000–2025 | ghoapi.azureedge.net | 2026-10-12 |
| WHO Global Tuberculosis Programme | Programme record | 140 | 16 | 2002–2025 | extranet.who.int | 2026-10-16 |
| Demographic and Health Surveys | Survey | 99 | 3 | 2009–2016 | api.dhsprogram.com | 2026-10-16 |
| Global Fund Data Service | Programme record | 94 | 9 | 2017–2025 | fetch.theglobalfund.org | 2026-10-12 |
| IATI, through d-portal | Expenditure account | 55 | 3 | 2000–2026 | d-portal.org | 2026-10-12 |
| OECD Creditor Reporting System | Expenditure account | 51 | 3 | 2002–2024 | sdmx.oecd.org | 2026-10-12 |
| World Bank Open Data | Modelled estimate | 51 | 2 | 2000–2025 | api.worldbank.org | 2026-10-12 |
| ForeignAssistance.gov | Expenditure account | 33 | 3 | 2003–2020 | foreignassistance.gov | 2026-10-29 |
| UNAIDS Global AIDS Monitoring expenditure database | Expenditure account | 31 | 11 | 2022–2024 | hivfinancial.unaids.org | 2026-10-12 |
| WHO HIV testing services dashboard | Programme record | 7 | 3 | 2022 | eic-database-290813.ew.r.appspot.com | 2026-10-14 |
| Global Fund allocations | Expenditure account | 4 | 1 | 2017–2026 | fetch.theglobalfund.org | 2026-10-12 |
| UNAIDS Data 2025 country databook | Expenditure account | 4 | 2 | 2022–2023 | aidsinfo.unaids.org | 2026-10-15 |
Indicators held
| Indicator | Domain | Unit | Rows | Years | Sources | Most recent value |
|---|---|---|---|---|---|---|
| Actual expenditure on collaborative TB/HIV activities | Financing | USD | 8 | 2017–2024 | WHO Global Tuberculosis Programme | $61k (2024) |
| Budget required for collaborative TB/HIV activities | Financing | USD | 8 | 2018–2025 | WHO Global Tuberculosis Programme | $3k (2025) |
| Country-reported HIV expenditure, all sources | Financing | USD | 6 | 2022–2024 | UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database | $2.3m (2024) |
| Domestic funding received by the national TB programme | Financing | USD | 5 | 2017–2024 | WHO Global Tuberculosis Programme | $1.1m (2024) |
| Domestic public HIV expenditure | Financing | USD | 5 | 2022–2024 | UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database | $1.4m (2024) |
| Expected Global Fund funding for the national TB programme | Financing | USD | 7 | 2018–2024 | WHO Global Tuberculosis Programme | $2.4m (2024) |
| Expected USAID funding for the national TB programme | Financing | USD | 4 | 2018–2025 | WHO Global Tuberculosis Programme | $0 (2025) |
| Expected domestic funding for the national TB programme | Financing | USD | 4 | 2018–2025 | WHO Global Tuberculosis Programme | $1.6m (2025) |
| Expected funding for collaborative TB/HIV activities | Financing | USD | 8 | 2018–2025 | WHO Global Tuberculosis Programme | $3k (2025) |
| External HIV financing (all donors, ODA) | Financing | USD | 23 | 2002–2024 | OECD Creditor Reporting System | $5.2m (2024) |
| External HIV financing from governments other than the United States (IATI) | Financing | USD | 25 | 2000–2026 | IATI, through d-portal | $23k (2026) |
| External HIV financing from multilateral bodies other than the Global Fund (IATI) | Financing | USD | 10 | 2012–2026 | IATI, through d-portal | $75k (2026) |
| External HIV financing from the United States (ODA) | Financing | USD | 24 | 2003–2020 | ForeignAssistance.gov, OECD Creditor Reporting System | $14k (2020) |
| Funding received for collaborative TB/HIV activities | Financing | USD | 8 | 2017–2024 | WHO Global Tuberculosis Programme | $61k (2024) |
| Global Fund HIV allocation for a whole three-year cycle, not an annual figure | Financing | USD per three-year allocation cycle | 4 | 2017–2026 | Global Fund allocations | 2,057,322 (2026) |
| Global Fund HIV disbursements to the country | Financing | USD | 41 | 2007–2026 | IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database | $110k (2026) |
| Global Fund funding received by the national TB programme | Financing | USD | 7 | 2017–2023 | WHO Global Tuberculosis Programme | $2.7m (2023) |
| HIV spending on TB/HIV co-infection | Financing | USD | 2 | 2022–2023 | UNAIDS Global AIDS Monitoring expenditure database | $7k (2023) |
| HIV spending on critical enablers | Financing | USD | 3 | 2022–2024 | UNAIDS Global AIDS Monitoring expenditure database | $13k (2024) |
| HIV spending on governance and sustainability | Financing | USD | 3 | 2022–2024 | UNAIDS Global AIDS Monitoring expenditure database | $790k (2024) |
| HIV spending on prevention | Financing | USD | 3 | 2022–2024 | UNAIDS Global AIDS Monitoring expenditure database | $1.2m (2024) |
| HIV spending on prevention of vertical transmission | Financing | USD | 3 | 2022–2024 | UNAIDS Global AIDS Monitoring expenditure database | $34k (2024) |
| HIV spending on programmes for children and adolescents | Financing | USD | 2 | 2022–2024 | UNAIDS Global AIDS Monitoring expenditure database | $583 (2024) |
| HIV spending on treatment, care and support | Financing | USD | 3 | 2022–2024 | UNAIDS Global AIDS Monitoring expenditure database | $353k (2024) |
| International HIV expenditure (country-reported) | Financing | USD | 5 | 2022–2024 | UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database | $937k (2024) |
| US HIV disbursements managed by USAID | Financing | USD | 7 | 2003–2020 | ForeignAssistance.gov | $14k (2020) |
| US HIV disbursements managed by other US agencies | Financing | USD | 12 | 2007–2020 | ForeignAssistance.gov | $0 (2020) |
| USAID funding received by the national TB programme | Financing | USD | 3 | 2017–2024 | WHO Global Tuberculosis Programme | $0 (2024) |
| % of ALL PLHIV who are virally suppressed | Treatment cascade | percent | 7 | 2021–2025 | UNAIDS AIDSinfo, WHO Global Health Observatory | 46.0% (2025) |
| % of PLHIV on ART (second 95, PLHIV base) | Treatment cascade | percent | 38 | 2000–2025 | UNAIDS AIDSinfo, WHO Global Health Observatory | 66.0% (2025) |
| % of PLHIV who have been diagnosed (first 95) | Treatment cascade | percent | 22 | 2014–2025 | UNAIDS AIDSinfo, WHO Global Health Observatory | 89.0% (2025) |
| % of estimated HIV-positive incident TB cases on TB treatment and ART | Treatment cascade | percent | 20 | 2003–2024 | UNAIDS AIDSinfo | 58.8% (2024) |
| % of people newly enrolled in HIV treatment diagnosed with TB disease | Treatment cascade | percent | 1 | 2014 | UNAIDS AIDSinfo | 39.3% (2014) |
| % of people newly enrolled in HIV treatment started on TB preventive therapy | Treatment cascade | percent | 1 | 2023 | UNAIDS AIDSinfo | 30.0% (2023) |
| % of people on ART who are virally suppressed (third 95) | Treatment cascade | percent | 4 | 2021–2025 | WHO Global Health Observatory | 70.0% (2025) |
| % of returned HIV test results that were positive | Treatment cascade | percent | 8 | 2022 | UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard | 0.4% (2022) |
| HIV self-test kits distributed | Treatment cascade | count | 1 | 2022 | WHO HIV testing services dashboard | 2,022 (2022) |
| HIV tests performed with the result returned to the person | Treatment cascade | count | 15 | 2018–2024 | Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard | 14,184 (2024) |
| HIV-exposed infants tested within two months of birth | Treatment cascade | percent | 3 | 2013–2022 | UNAIDS AIDSinfo | 25.0% (2022) |
| HIV-positive TB patients started or continued on ART | Treatment cascade | count | 19 | 2015–2025 | Global Fund Data Service, WHO Global Tuberculosis Programme | 76 (2025) |
| Key-population people tested for HIV (count over the period) | Treatment cascade | count | 24 | 2018–2025 | Global Fund Data Service | By population group, sex or age only, to 2025 |
| New HIV diagnoses with a CD4 count below 200 | Treatment cascade | percent | 1 | 2019 | UNAIDS AIDSinfo | 23.0% (2019) |
| Number of people on ART (PEPFAR MER TX_CURR) | Treatment cascade | count | 73 | 2000–2025 | Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory | 1,421 (2025) |
| People living with HIV on ART who started TB preventive therapy | Treatment cascade | count | 3 | 2021–2023 | Global Fund Data Service | 73 (2023) |
| People newly enrolled on ART during the year | Treatment cascade | count | 7 | 2014–2025 | Global Fund Data Service, WHO Global Tuberculosis Programme | 316 (2025) |
| People tested for HIV in the last 12 months who received the result (household survey) | Treatment cascade | percent | 28 | 2016 | Demographic and Health Surveys | By population group, sex or age only, to 2016 |
| Pregnant women tested for HIV in antenatal care | Treatment cascade | percent | 10 | 2015–2024 | UNAIDS AIDSinfo | 72.0% (2024) |
| Pregnant women with HIV who received ARVs for PMTCT | Treatment cascade | count | 38 | 2010–2025 | Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory | 27 (2025) |
| TB patients recorded as HIV-positive | Treatment cascade | count | 10 | 2015–2024 | WHO Global Tuberculosis Programme | 59 (2024) |
| TB patients with an HIV test result recorded | Treatment cascade | count | 15 | 2015–2025 | Global Fund Data Service, WHO Global Tuberculosis Programme | 4,859 (2025) |
| AIDS-related deaths | Epidemic estimates | count | 295 | 2000–2025 | UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory | 100 (2025) |
| Deaths from TB among people living with HIV | Epidemic estimates | count | 46 | 2002–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 23 (2024) |
| HIV prevalence among a key population | Epidemic estimates | percent | 2 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| HIV prevalence, ages 15-49 | Epidemic estimates | percent | 50 | 2000–2024 | UNAIDS AIDSinfo, World Bank Open Data | 0.2% (2024) |
| Incident TB cases among people living with HIV | Epidemic estimates | count | 46 | 2002–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 95 (2024) |
| New HIV infections | Epidemic estimates | count | 295 | 2000–2025 | UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory | 200 (2025) |
| People living with HIV | Epidemic estimates | count | 295 | 2000–2025 | UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory | 2,200 (2025) |
| Condom use at last higher-risk sex (household survey) | Prevention and outreach | percent | 11 | 2009–2016 | Demographic and Health Surveys | By population group, sex or age only, to 2016 |
| Key-population people reached by outreach (count over the period) | Prevention and outreach | count | 24 | 2018–2025 | Global Fund Data Service | By population group, sex or age only, to 2025 |
| Male condoms distributed in a year | Prevention and outreach | count | 2 | 2022–2023 | UNAIDS AIDSinfo | 3,414,528 (2023) |
| People with comprehensive correct knowledge of HIV (household survey) | Prevention and outreach | percent | 60 | 2009–2016 | Demographic and Health Surveys | By population group, sex or age only, to 2016 |
| Estimated size of a key population | Population denominators | count | 3 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| Total population | Population denominators | count | 26 | 2000–2025 | World Bank Open Data | 1,418,517 (2025) |
Every row shown on the Timor-Leste page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.
Turn your phone to read the chart upright